Cidara Therapeutics, Inc. (CDTX)
220.19
+0.59
(+0.27%)
USD |
NASDAQ |
Dec 11, 16:00
220.36
+0.17
(+0.08%)
After-Hours: 20:00
Cidara Therapeutics Research and Development Expense (Quarterly): 35.53M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Merck & Co., Inc. | 3.552B |
| Bristol Myers Squibb Co. | 2.433B |
| Johnson & Johnson | 3.693B |
| Mersana Therapeutics, Inc. | 12.07M |
| Pfizer Inc. | 2.492B |